Karista — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Waivwaiv.comMar 2026 · $33M
Waiv develops AI-based diagnostic tests for precision oncology, using machine learning and foundation models to support biomarker discovery and multimodal diagnostic workflows.
AI & Machine LearningBiotechDigital Health
Co-investorsSerenaSistaAlpha Intelligence CapitalOTB Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.